[144] ACUREN CORP SEC Filing
TIC reports a planned sale of restricted or control securities under Rule 144. A company affiliate intends to sell 52,467 common shares through Merrill Lynch, Pierce, Fenner & Smith Inc. on the NYSE, with an approximate aggregate market value of
The notice states that there were 220,559,713 common shares outstanding at the time referenced. The shares to be sold were acquired from the issuer as compensation on several dates, including
- None.
- None.
FAQ
What does TIC's latest Form 144 filing report?
TIC's Form 144 notice reports that an affiliate plans to sell 52,467 shares of common stock on the NYSE through Merrill Lynch, Pierce, Fenner & Smith Inc., with an approximate aggregate market value of
How many TIC shares are planned to be sold under this Form 144?
The filing indicates that 52,467 common shares of TIC are proposed to be sold, with an approximate aggregate market value of
When is the TIC Form 144 sale expected to take place?
The notice lists an approximate date of sale of
Through which broker and exchange will TIC shares be sold in this Form 144?
The planned sale will be executed through Merrill Lynch, Pierce, Fenner & Smith Inc., located in Miami, Florida, and the shares are listed for sale on the NYSE.
How many TIC shares were outstanding compared to the amount being sold?
The Form 144 indicates there were 220,559,713 TIC common shares outstanding, compared with the planned sale of 52,467 shares under this notice.
How and when were the TIC shares being sold under Form 144 acquired?
The shares were acquired from the issuer as compensation on several dates, including
Does the TIC Form 144 include any representation about undisclosed information?
Yes. By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about TIC's current or prospective operations that has not been publicly disclosed.